Related Experiment Video
Updated: Apr 12, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
Published on: November 17, 2015
Comparison of nanoparticle penetration into solid tumors and sites of inflammation: studies using targeted and
Scott Poh1,2, Venkatesh Chelvam1,3, Philip S Low1
11Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA.
Aim:
The vast majority of nanomedicine research is focused on the use of nanoparticles for the diagnosis and treatment of cancer. However, the dense extracellular matrix of solid tumors restricts nanoparticle penetration, raising the question of whether the best applications of nanomedicines lie in oncology.
Materials & Methods:
In this study, the uptake of folate-conjugated liposomes was compared between folate receptor-expressing tumors and folate receptor+ inflammatory lesions within the same mouse.
Results:
We demonstrate here that both folate-targeted and nontargeted liposomes accumulate more readily at sites of inflammation than in solid tumors.
Conclusion:
These data suggest that nanosized imaging and therapeutic agents may be better suited for the treatment and diagnosis of inflammatory/autoimmune diseases than cancer.
Insights
Nanoparticle delivery agents accumulate better in inflammatory sites than solid tumors. This suggests nanomedicines may be more effective for treating inflammatory diseases than cancer.
Area of Science:
- Nanomedicine
- Oncology
- Immunology
Background:
- Nanomedicine research heavily focuses on cancer diagnosis and treatment.
- Solid tumors' dense extracellular matrix hinders nanoparticle penetration.
- This raises questions about nanomedicines' optimal applications in oncology.
Purpose of the Study:
- To compare nanoparticle uptake in tumors versus inflammatory lesions.
- To investigate the potential of nanomedicines beyond oncology.
Main Methods:
- Utilized folate-conjugated liposomes for targeted delivery.
- Compared liposome uptake in folate receptor-expressing tumors and inflammatory lesions within the same mouse model.
Main Results:
- Both targeted and nontargeted liposomes showed higher accumulation at inflammatory sites compared to solid tumors.
- Demonstrated differential accumulation based on lesion type, not solely targeting.
Conclusions:
- Nanosized agents may be more suitable for diagnosing and treating inflammatory and autoimmune diseases.
- Current nanomedicine applications might be better directed away from solid tumors.
- Suggests a paradigm shift in nanomedicine research focus.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Bioavailability Enhancement: Drug Permeability Enhancement

